Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS

Biological Chemistry

Volumn 385, Issue 3-4, 2004, Pages 331-339

  Donner, Markus G ^a   Warskulat, Ulrich ^a   Saha, Nirmalendu ^a,b   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

ABC transporters; Cholestasis; Hepatobiliary transport; Multidrug resistance proteins

Indexed keywords

CYCLIC NUCLEOTIDE; GLUTAMATE AMMONIA LIGASE; ISOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CHOLESTASIS; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; GENE INDUCTION; LIVER; LIVER CELL; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; UPREGULATION;

ANIMALS; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 2542471454     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.029     Document Type: Article

References (83)

1. Aiso, M., Takikawa, H., and Yamanaka, M. (2000). Biliary excretion of bile acids and organic anions in zone 1- and zone 3-injured rats. Liver 20, 38-44.
2. Akita, H., Suzuki, H., Hirohashi, T., Takikawa, H., and Sugiyama, Y. (2002). Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm. Res. 19, 34-41.
3. Beigneux, A.P., Moser, A.H., Shigenaga, J.K., Grunfeld, C., and Feingold, K.R. (2002). Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 293, 145-149.
4. Belinsky, M.G., Chen, Z.S., Shchaveleva, I., Zeng, H., and Kruh, G.D. (2002). Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62, 6172-6177.
5. Bergen, A.A., Plomp, A.S., Schuurman, E.J., Terry, S., Breuning, M., Dauwerse, H., Swart, J., Kool, M., van Soest, S., Baas, F. et al. (2000). Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25, 228-231.
6. Bohan, A., Chen, W.S., Denson, L.A., Held, M.A., and Boyer, J.L. (2003). Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 38, 36688-36698.
7. Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., and Keppler, D. (1996). cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic rats. J. Biol. Chem. 271, 15091-15098.
8. Buhler, R., Lindros, K.O., Nordling, A., Johansson, I., and Ingelman-Sundberg, M. (1992). Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem. 204, 407-412.
9. Cantz, T., Nies, A.T., Brom, M., Hofmann, A.F., and Keppler, D. (2000). MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G522-G531.
10. Chen, Z.S., Lee, K., and Kruh, G.D. (2001). Transport of cyclic nucleotides and estradiol 17-β-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 276, 33747-33754.
11. Chen, Z.S., Lee, K., Walther, S., Raftogianis, R.B., Kuwano, M., Zeng, H., and Kruh, G.D. (2002). Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 62, 3144-3150.
12. Dombrowski, F., Kubitz, R., Chittattu, A., Wettstein, M., Saha, N., and Häussinger, D. (2000). Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem. J. 348, 183-188.
13. Donner, M.G., and Keppler, D. (2001). Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34, 351-359.
14. Gao, C., Jokerst, R., Gondipalli, P., Cai, S.R., Kennedy, S., Flye, M.W., and Ponder, K.P. (1999). Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity. Hepatology 30, 1405-1416.
15. Gascon-Barre, M., Benbrahim, N., and Tremblay, C. (1989). Hepatic zonation of drug-metabolizing enzymes. Studies on hepatocytes isolated from the periportal or perivenous region of the liver acinus. Can. J. Physiol. Pharmacol. 67, 1015-1022.
16. Gebhardt, R., and Mecke, D (1983). Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J. 2, 567-570.
17. Geier, A., Dietrich, C.G., Voigt, S., Kim, S.K., Gerloff, T., Kullak-Ublick, G.A., Lorenzen, J., Matern, S., and Gartung, C. (2003). Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38, 345-354.
18. Geller, D.A., Nussler, A.K., Di Silvio, M., Lowenstein, C.J, Shapiro, R.A., Wang, S.C., Simmons, R.L., and Billiar, T.R. (1993). Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90, 522-526.
19. Graber, S.E., and Clancey, M.A. (1985). Further characterization of the effect of bacterial lipopolysaccharide preparations on cyclic GMP levels: the importance of macromolecular synthesis. Proc. Soc. Exp. Biol. Med. 180, 163-169.
20. Groothuis, G.M., Hardonk, M.J., Keulemans, K.P., Nieuwenhuis, P., and Meijer, D.K. (1982). Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am. J. Physiol. 243, G455-462.
21. Häussinger, D. (1983) Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur. J. Biochem. 133, 269-275.
22. Häussinger, D., and Stehle, T. (1988). Hepatocyte heterogeneity in response to icosanoids. The perivenous scavenger cell hypothesis. Eur. J. Biochem. 175, 395-403.
23. Häussinger, D., Stoll, B., Stehle, T., and Gerok, W. (1989). Hepatocyte heterogeneity in glutamate metabolism and bidirectional transport in perfused rat liver. Eur. J. Biochem. 185, 189-195.
24. Hartmann, G., Cheung, A.K., and Piquette-Miller, M. (2002). Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther. 303, 273-281.
25. Hattori, M., Tugores, A., Westwick, J.K., Veloz, L., Leffert, H.L., Karin, M., and Brenner, D.A. (1993). Activation of activating protein 1 during hepatic acute phase response. Am. J. Physiol. 264, G95-103.
26. Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., and Sugiyama, Y. (1998). Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol. Pharmacol. 53, 1068-1075.
27. Hirohashi, T., Suzuki, H., and Sugiyama, Y. (1999). Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J. Biol. Chem. 274, 15181-5185.
28. Hirohashi, T., Suzuki, H., Takikawa, H., and Sugiyama, Y. (2000). ATP-dependent transport of bile salts by rat multidrug resistance protein 3 (mrp3). J. Biol. Chem. 275, 2905-2910.
29. Hooiveld, G.J., van Montfoort, J.E., Meijer, D.K., and Müller, M. (2001). Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport. Eur. J. Pharm. Sci. 12, 525-543.
30. Iliás, A., Urban, Z., Seidl, T.L., Le Saux, O., Sinko,E., Boyd, C.D., Sarkadi, B., and Varadi, A. (2002). Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J. Biol. Chem. 277, 16860-16867.
31. Jedlitschky, G., Burchell, B., and Keppler, D. (2000). The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275, 30069-30074.
32. Jungermann, K., and Katz, N. (1989). Functional specialization of different hepatocyte populations. Physiol. Rev. 69, 708-764.
33. Keppler, D., and König, J. (2000). Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis. 20, 265-272.
34. König, J., Rost, D., Cui, Y., and Keppler, D. (1999a). Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29, 1156-1163.
35. König, J., Nies, A.T., Cui, Y., Leier, I., and Keppler D. (1999b). Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1461, 377-394.
36. Kool, M., de Haas, M., Scheffer, G.L., Scheper, R.J., van Eijk, M.J., Juijn, J.A., Baas, F., and Borst, P. (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57, 3537-3547.
37. Kool, M., van der Linden, M., de Haas, M., Baas, F., and Borst, P. (1999). Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59, 175-82.
38. Kubitz, R., D'Urso, D., Keppler, D., and Häussinger, D. (1997). Osmodependent dynamic localisation of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane. Gastroenterology 113, 1438-1442.
39. Kubitz, R., Wettstein, M., Warskulat, U., and Häussinger, D. (1999). Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116, 401-410.
40. Lai, L., and Tan, T.M. (2002). Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem. J. 361, 497-503.
41. Lee, G., and Piquette-Miller, M. (2001). Influence of II-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can. J. Physiol. Pharmacol. 79, 867-884.
42. Madon, J., Hagenbuch, B., Landmann, L., Meier, P.J., and Stieger, B. (2000). Transport function and hepatocellular localization of mrp6 in rat liver. Mol. Pharmacol. 57, 634-641.
43. McAleer, M.A., Breen, M.A., White, N.L., and Matthews, N. (1999). pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem. 274, 23541-23548.
44. Meloni, I., Rubegni, P., De Aloe, G., Bruttini, M., Pianigiani, E., Cusano, R., Seri, M., Mondillo, S., Federico, A., Bardelli, A.M. et al. (2001). Pseudoxanthoma elasticum: Point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11. Hum. Mutat. 18, 85.
45. Morimoto, Y., Wettstein, M., and Häussinger, D. (1993). Hepatocyte heterogeneity in response to extracellular adenosine. Biochem. J. 293, 573-581.
46. Mottino, AD., Cao, J., Veggi, L.M., Crocenzi, F., Roma, M.G., and Vore, M. (2002). Altered localization and activity of canalicular Mrp2 in estradiol-17-β-D-glucuronide-induced cholestasis. Hepatology 35, 1409-1419.
47. Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P.J., Hirose, K., Akizawa, T., Yoshioka, M., and Sugiyama, Y. (2000). Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. Gastroinest. Liver Physiol. 278, G438-G446.
48. Pascussi, J.M., Gerbal-Chaloin, S., Pichard-Garcia, L., Daujat, M., Fabre, J.M., Maurel, P., Vilarem, M.J. (2000). Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun. 274, 707-713.
49. Paulusma, C.C., Kothe, M.J.C., Bakker, C.T.M., Bosma, P., van Bokhoven, I., van Marle J., Bolder, U., Tytgat, G.N., and Oude Elferink, R.P. (2000). Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31, 684-693.
50. Ringpfeil, F., Lebwohl, M.G., Christiano, A.M., and Uitto, J. (2000). Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. USA 97, 6001-6006.
51. Ringpfeil, F., Nakano, A., Uitto, J., and Pulkkinen, L. (2001). Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum. Am. J. Hum. Genet. 68, 642-652.
52. Rius, M., Nies, A.T., Hummel-Eisenbeiss, J., Jedlitschky, G., and Keppler, D. (2003). Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38, 374-384.
53. Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., and Borst, P. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 100, 9244-9249.
54. Roelofsen, H., Schoemaker, B., Bakker, C., Ottenhoff, R., Jansen, P.L., and Elferink, R.P. (1995). Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am. J. Physiol. 269, G427-434.
55. Sadzuka, Y., Sugiyama, T., Suzuki, T., and Sonobe, T. (2001). Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett. 123, 159-167.
56. Sang, H., Wallis, G.L., Stewart, C.A., and Kotake, Y. (1999). Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch. Biochem. Biophys. 363, 341-348.
57. Scevola, D., Barbarini, G., Marone, P., Casciarri, I., Bernardi, R., and Magliulo, E. (1980). Bacterial toxins and glucagon in liver cAMP regulation: a physiopathological role in liver diseases. Boll. 1st. Sieroter. Milan. 59, 655-661.
58. Scheffer, G.L., Hu, X., Pijnenborg, A.C., Wijnholds, J., Bergen, A.A., and Scheper, R.J. (2000). MRP6 (ABCC6) detection in normal human tissues and tumors. Lab. Invest. 82, 515-518.
59. Scheffer, G.L., Kool, M., de Haas, M., de Vree, J.M., Pijnenborg, A.C., Bosman, D.K., Elferink, R.P., van der Valk, P., Borst, P., and Scheper, R.J. (2002). Tissue distribution and induction of human multidrug resistant protein 3. Lab. Invest. 82, 193-201.
60. Schmitt, M., Kubitz, R., Wettstein, M., vom Dahl, S., and Häussinger, D. (2000). Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene. Biol. Chem. 381, 487-495.
61. Schuetz, E.G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R.B., Ramachandran, V., Komoroski, B.J. et al. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 276, 39411-39418.
62. Shoda, J., Kano, M., Oda, K., Kamiya, J., Nimura, Y., Suzuki, H., Sugiyama, Y., Miyazaki, H., Todoroki, T., Stengelin, S. et al. (2001). The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 96, 3368-3378.
63. Smith, D.D. Jr., and Campbell, J.W. (1988). Distribution of glutamine synthetase and carbamoyl-phosphate synthetase I in vertebrate liver. Proc. Natl. Acad. Sci. USA 85, 160-164.
64. Soroka, C.J., Lee, J.M., Azzaroli, F., and Boyer, J. (2001). Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes; and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33, 783-791.
65. Spitzer, J.A. (1994). Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology 19, 217-228.
66. Staudinger, J.L., Madan, A., Carol, K.M., and Parkinson A. (2003). Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 31, 523-527.
67. Stoll, B., and Häussinger, D. (1989). Functional hepatocyte heterogeneity: Vascular 2-oxoglutarate is almost exclusively taken up by perivenous, glutamine-synthetase-containing hepatocytes. Eur. J. Biochem. 181, 709-716.
68. Stoll, B., and Häussinger, D. (1991). Hepatocyte heterogeneity in uptake and metabolism of malate and related dicarboxylates. Eur. J. Biochem. 195, 121-129.
69. Stoll, B., McNelly, S., Buscher, H.P., and Häussinger D. (1991). Functional hepatocyte heterogeneity in glutamate, aspartate and aketoglutarate uptake: a histoautoradiographical study. Hepatology 13, 247-253.
70. Trauner, M., Arrese, M., Soroka, C.J., Ananthanarayanan, M., Koeppel, T.A., Schlosser, S.F., Suchy F.J., Keppler, D., and Boyer, J.L. (1997a). The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113, 255-264.
71. - excretion and blocks the choleretic effect of nitric oxide in rat liver. Hepatology 25, 1184-1191.
72. Trauner, M., Fickert, P., and Stauber, R.E. (1999). Inflammation-induced cholestasis. J. Gastroenterol. Hepatol. 14, 946-959.
73. Trauner, M., and Boyer, J.L. (2003). Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83, 633-671.
74. Twisk, J., Hoekman, M.F., Mager, W.H., Moorman, A.F., de Boer, P.A., Scheja, L., Princen, H.M., and Gebhardt R. (1995). Heterogeneous expression of cholesterol 7 α-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus. J. Clin. Invest. 95, 1235-1243.
75. Tzeng, S.J., and Huang, J.D. (2002). Transcriptional regulation of the rat Mrp3 promoter in intestine cells. Biochem. Biophys. Res. Commun. 291, 270-277.
76. Vos, T.A., Hooiveld, G.J.E.J., Koning, H., Childs, S., Meijer, D.K.F., Moshage, H., Jansen, P.L.M., and Müller, M. (1998). Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28, 1637-1644.
77. Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G.L., Schuetz, J.D., Gonzalez, F.J. et al. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125, 825-838.
78. Wielinga, P.R., van der Heijden, I., Reid, G., Beijnen, J.H., Wijnholds, J., and Borst, P. (2003). Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J. Biol. Chem. 278, 17664-17671.
79. Wijnholds, J., Mol, C.A., van Deemter, L., de Haas, M., Scheffer, G.L., Baas, F., Beijnen, J.H., Scheper, R.J., Hatse, S., De Clereq, E. et al. (2000). Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA 97, 7476-7481.
80. Zelcer, N., Saeki, T., Reid, G., Beijnen, J.H., and Borst, P. (2001). Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276, 46400-46407.
81. Zelcer, N., Reid, G., Wielinga, P., Kuil, A., van der Heijden, I., Schuetz, J.D., and Borst P. (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem. J. 371, 361-367.
82. Zeng, H., Liu, G., Rea, P.A., and Kruh, G.D. (2000). Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60, 4779-4784.
83. Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.U., Zatloukal, K., Denk, H., and Trauner, M. (2003). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J. Hepatol. 38, 717-727.